Discover Tenders by Vending Machine Ingredients Sector

Find the most relevant tenders for Vending Machine Ingredients. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Vending Machine Ingredients tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Vending Machine Ingredients tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Timolol And Latanoprost S01Ed61 Within The Framework Of A So Called Open House Mod

Deadline: 31 Jul 2026

Germany

Ref. No.: 7681822

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Silodosin G04Ca04 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7680910

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Budesonide A07Ea06 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7679307

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Glyceryl Trinitrate C01Da02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7678980

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Trastuzumab L01Fd01 Only Sc Dosage Form As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7677928

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Colecalciferol A11Cc05 Excluding Rx Range Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7677788

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Mitomycin L01Dc03 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7676937

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ciclopirox D01Ae14 G01Ax12 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7676859

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sorafenib L01Ex02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7676157

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Epinephrine C01Ca24 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7675399

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 7674853

EMD:Ref Document

Bid Value: Ref Document

657 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Telmisartan C09Ca07 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7674458

EMD:Ref Document

Bid Value: Ref Document

341 Days Left

Deciphering The Impact Of Exposures From The Gut Microbiome Derived Molecular Complex In Human Health And Disease

Deadline: 31 Oct 2025

Luxembourg

Ref. No.: 7647385

EMD:Ref Document

Bid Value: Ref Document

68 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 7638620

EMD:Ref Document

Bid Value: Ref Document

494 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat Atc Code M04Aa03

Deadline: 28 Jul 2026

Germany

Ref. No.: 7538541

EMD:Ref Document

Bid Value: Ref Document

338 Days Left

Showing 10666 to 10680 of 11156 results

Discover Tenders by Vending Machine Ingredients Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Vending Machine Ingredients Sector

Filter Your Search

FREE Trial plan for all new users!